News Novo posts strong performance, but US pricing pressure grows Pharmacy benefit managers and arrival of biosimilars making life difficult for diabetes companies
News Novo to expand world's biggest insulin production site World's largest insulin plant is to get bigger.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News Sanofi's diabetes combo on target for showdown with Novo Rival insulin and GLP-1 combinations under review in US.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
